Low-Dose Computed Tomographic Screening for Lung Cancer

Clinics in Chest Medicine

Volumn 36, Issue 2, 2015, Pages 147-160

  Christensen, Jared D ^a   Chiles, Caroline ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

Author keywords

Computed tomography (CT); Lung cancer; Screening

Indexed keywords

ANXIETY; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL DECISION MAKING; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY CALCIFICATION; FALSE POSITIVE RESULT; HIGH RISK PATIENT; HUMAN; INCIDENTAL FINDING; INTERSTITIAL LUNG DISEASE; KIDNEY CANCER; LUNG CANCER; LUNG EMPHYSEMA; LUNG NODULE; LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; REVIEW; RISK ASSESSMENT; SMOKING; EARLY CANCER DIAGNOSIS; LUNG TUMOR; PROCEDURES; RADIOGRAPHY;

EARLY DETECTION OF CANCER; HUMANS; LUNG NEOPLASMS; RADIATION DOSAGE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84930180397     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2015.02.002     Document Type: Review

References (50)

1. Siegel R., Ma J., Zou Z., et al. Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
2. National Lung Screening Trial Research Team, Aberle D.R., Adams A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. NEngl J Med 2011, 365:395-409.
3. Aberle D.R., DeMello S., Berg C.D., et al. Results of the two incidence screenings in the National Lung Screening Trial. NEngl J Med 2013, 369:920-931.
4. Detterbeck F.C., Postmus P.E., Tanoue L.T. The stage classification of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143:e191S-e210S.
5. Shepherd F.A., Crowley J., Van Houtte P., et al. The International Association for the Study of Lung Cancer lung cancer staging project: proposals regarding the clinical staging of small cell lung cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for lung cancer. JThorac Oncol 2007, 2:1067-1077.
6. van der Aalst C.M., van Iersel C.A., van Klaveren R.J., et al. Generalisability of the results of the Dutch-Belgian randomised controlled lung cancer CT screening trial (NELSON): does self-selection play a role?. Lung Cancer 2012, 77:51-57.
7. van Iersel C.A., de Koning H.J., Draisma G., et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007, 120:868-874.
8. Pedersen J.H., Ashraf H., Dirksen A., et al. The Danish randomized lung cancer CT screening trial-overall design and results of the prevalence round. JThorac Oncol 2009, 4:608-614.
9. Heuvelmans M.A., Oudkerk M., de Bock G.H., et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 2013, 23:1836-1845.
10. Xu D.M., Gietema H., de Koning H., et al. Nodule management protocol of the NELSON randomised lung cancer screening trial. Lung Cancer 2006, 54:177-184.
11. Horeweg N., Scholten E.T., de Jong P.A., et al. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers. Lancet Oncol 2014, 15(12):1342-1350.
12. National Comprehensive Cancer Network (NCCN) Lung Cancer Screening Guidelines Version 1.2015. Available at: Accessed October 12, 2014. http://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf.
13. Moyer V.A., U.S.Preventive Services Task Force Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014, 160:330-338.
14. Wender R., Fontham E.T., Barrera E., et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin 2013, 63:107-117.
15. National Lung Screening Trial Research Team, Church T.R., Black W.C., et al. Results of initial low-dose computed tomographic screening for lung cancer. NEngl J Med 2013, 368:1980-1991.
16. Gierada D.S., Pinsky P., Nath H., et al. Projected outcomes using different nodule sizes to define a positive CT lung Cancer screening examination. JNatl Cancer Inst 2014, 106-112.
17. Patz E.F., Pinsky P., Gatsonis C., et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014, 174:269-274.
18. Loeb S., Bjurlin M.A., Nicholson J., et al. Overdiagnosis and overtreatment of prostate cancer. Eur Urol 2014, 65:1046-1055.
19. Gotzsche P.C., Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2011, (1). CD001877.
20. Etzioni R., Penson D.F., Legler J.M., et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. JNatl Cancer Inst 2002, 94:981-990.
21. Larke F.J., Kruger R.L., Cagnon C.H., et al. Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. AJR Am J Roentgenol 2011, 197:1165-1169.
22. Mettler F.A., Huda W., Yoshizumi T.T., et al. Effective doses in radiology and diagnostic nuclear medicine: a catalog. Radiology 2008, 248:254-263.
23. Mascalchi M., Mazzoni L.N., Falchini M., et al. Dose exposure in the ITALUNG trial of lung cancer screening with low-dose CT. Br J Radiol 2012, 85:1134-1139.
24. Einstein A.J., Henzlova M.J., Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA 2007, 298:317-323.
25. Berrington de Gonzalez A., Kim K.P., Berg C.D. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. JMed Screen 2008, 15:153-158.
26. Manowitz A., Sedlar M., Griffon M., et al. Use of BMI guidelines and individual dose tracking to minimize radiation exposure from low-dose helical chest CT scanning in a lung cancer screening program. Acad Radiol 2012, 19:84-88.
27. American College of Radiology (ACR) Lung CT Screening Reporting and Data System (Lung-RADS) Version 1.0. Available at: Accessed September 4, 2014. http://www.acr.org/Quality-Safety/Resources/LungRADS.
28. Horeweg N., van Rosmalen J., Heuvelmans M.A., et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 2014, 15(12):1332-1341.
29. Ahn M.I., Gleeson T.G., Chan I.H., et al. Perifissural nodules seen at CT screening for lung cancer. Radiology 2010, 254:949-956.
30. Henschke C.I., Yankelevitz D.F., Mirtcheva R., et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002, 178:1053-1057.
31. Mets O.M., Buckens C.F., Zanen P., et al. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. JAMA 2011, 306:1775-1781.
32. Han M.K., Agusti A., Calverley P.M., et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010, 182:598-604.
33. Friedlander A.L., Lynch D., Dyar L.A., et al. Phenotypes of chronic obstructive pulmonary disease. COPD 2007, 4:355-384.
34. Mets O.M., Zanen P., Lammers J.W., et al. Early identification of small airways disease on lung cancer screening CT: comparison of current air trapping measures. Lung 2012, 190(6):629-633.
35. Tammemagi M.C., Katki H.A., Hocking W.G., et al. Selection criteria for lung-cancer screening. NEngl J Med 2013, 368:728-736.
36. Tammemagi C.M., Pinsky P.F., Caporaso N.E., et al. Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation. JNatl Cancer Inst 2011, 103:1058-1068.
37. Hidalgo A., Franquet T., Gimenez A., et al. Smoking-related interstitial lung diseases: radiologic-pathologic correlation. Eur Radiol 2006, 16:2463-2470.
38. Hansell D.M., Nicholson A.G. Smoking-related diffuse parenchymal lung disease: HRCT-pathologic correlation. Semin Respir Crit Care Med 2003, 24:377-392.
39. Heyneman L.E., Ward S., Lynch D.A., et al. Respiratory bronchiolitis, respiratory bronchiolitis-associated interstitial lung disease, and desquamative interstitial pneumonia: different entities or part of the spectrum of the same disease process?. AJR Am J Roentgenol 1999, 173:1617-1622.
40. Jin G.Y., Lynch D., Chawla A., et al. Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate. Radiology 2013, 268:563-571.
41. Jacobs P.C., Gondrie M.J., van der Graaf Y., et al. Coronary artery calcium can predict all-cause mortality and cardiovascular events on low-dose CT screening for lung cancer. AJR Am J Roentgenol 2012, 198:505-511.
42. Mets O.M., Vliegenthart R., Gondrie M.J., et al. Lung cancer screening CT-based prediction of cardiovascular events. JACC Cardiovasc Imaging 2013, 6:899-907.
43. Shemesh J., Henschke C.I., Shaham D., et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology 2010, 257:541-548.
44. Rampinelli C., Preda L., Maniglio M., et al. Extrapulmonary malignancies detected at lung cancer screening. Radiology 2011, 261:293-299.
45. Swensen S.J., Jett J.R., Hartman T.E., et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology 2003, 226:756-761.
46. McKee B.J., Regis S.M., McKee A.B., et al. Performance of ACR Lung-RADS in a Clinical CT Lung Screening Program. JAm Coll Radiol 2015, 12:273-276.
47. Henschke C.I., Yip R., Yankelevitz D.F., International Early Lung Cancer Action Program Investigators, et al. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med 2013, 158:246-252.
48. Munden R.F., Godoy M.C. Lung cancer screening: state of the art. JSurg Oncol 2013, 108:270-274.
49. Patient Protection and Affordable Care Act. (Public Law 111-148), 2010. Available at: Accessed September 4, 2014. https://www.healthcare.gov/where-can-i-read-the-affordable-care-act/.
50. Proposed decision memo for screening for lung cancer with low dose computed tomography (LDCT) (CAG-00439N). Available at: Accessed September 4, 2014. http://www.cms.gov/medicare-coverage-database/details/nca-proposed-decision-memo.aspx?NCAId=274.